InsiderClue
Insiders · Profile

Labrucherie Gil M

Chief Financial Officer at Septerna · SVP, COO & CFO at NEKTAR THERAPEUTICS · Director at Rezolute. Filing since 14 Nov 2008. CIK 0001394875

SEPN Septerna, Inc. Chief Financial Officer · 5 trades NKTR NEKTAR THERAPEUTICS SVP, COO & CFO · 58 trades RZLT Rezolute, Inc. Director · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
SEPN Septerna, Inc.
27 Feb 2025
Chief Financial Officer
Bought
3,718
$21.75K
10.2%
SEPN Septerna, Inc.
25 Feb 2025
Chief Financial Officer
Bought
6,282
$35.12K
20.9%
SEPN Septerna, Inc.
21 Feb 2025
Chief Financial Officer
Bought
5,000
$29.25K
20.0%
SEPN Septerna, Inc.
20 Feb 2025
Chief Financial Officer
Bought
14,500
$85.23K
138%
SEPN Septerna, Inc.
19 Feb 2025
Chief Financial Officer
Bought
10,500
$57.81K
opened
NKTR NEKTAR THERAPEUTICS
16 May 2022
SVP, COO & CFO
Sold, plan not stated
17,448
$68.92K
5.3%
RZLT Rezolute, Inc.
4 May 2022
Director
Bought
52,631
$200.00K
opened
NKTR NEKTAR THERAPEUTICS
16 Feb 2022
SVP, COO & CFO
Sold, plan not stated
7,579
$82.99K
2.5%
NKTR NEKTAR THERAPEUTICS
18 Nov 2021
SVP, COO & CFO
Sold, plan not stated
3,000
$38.07K
1.2%
NKTR NEKTAR THERAPEUTICS
16 Nov 2021
SVP, COO & CFO
Sold, plan not stated
21,149
$278.32K
7.5%
NKTR NEKTAR THERAPEUTICS
17 Aug 2021
SVP, COO & CFO
Sold, plan not stated
3,000
$40.68K
1.2%
NKTR NEKTAR THERAPEUTICS
16 Aug 2021
SVP, COO & CFO
Sold, plan not stated
7,867
$108.80K
3.1%
NKTR NEKTAR THERAPEUTICS
17 May 2021
SVP, COO & CFO
Sold, plan not stated
7,898
$144.53K
3.0%
NKTR NEKTAR THERAPEUTICS
16 Feb 2021
SVP, COO & CFO
Sold, plan not stated
7,977
$178.45K
3.0%
NKTR NEKTAR THERAPEUTICS
4 Feb 2021
SVP, COO & CFO
Sold, plan not stated
50,000
$990.50K
15.8%
NKTR NEKTAR THERAPEUTICS
3 Feb 2021
SVP, COO & CFO
Sold, plan not stated
50,000
$980.50K
15.8%
NKTR NEKTAR THERAPEUTICS
2 Feb 2021
SVP, COO & CFO
Sold, plan not stated
50,000
$1.01M
15.8%
NKTR NEKTAR THERAPEUTICS
16 Nov 2020
SVP, COO & CFO
Sold, plan not stated
8,276
$140.11K
3.5%
NKTR NEKTAR THERAPEUTICS
17 Sep 2020
SVP, COO & CFO
Sold, plan not stated
2,000
$39.92K
0.8%
NKTR NEKTAR THERAPEUTICS
18 Aug 2020
SVP, COO & CFO
Sold, plan not stated
2,000
$39.36K
0.8%
NKTR NEKTAR THERAPEUTICS
17 Aug 2020
SVP, COO & CFO
Sold, plan not stated
6,245
$122.84K
2.5%
NKTR NEKTAR THERAPEUTICS
19 May 2020
SVP, COO & CFO
Sold, plan not stated
2,000
$45.24K
0.8%
NKTR NEKTAR THERAPEUTICS
18 May 2020
SVP, COO & CFO
Sold, plan not stated
5,727
$128.91K
2.3%
NKTR NEKTAR THERAPEUTICS
18 Feb 2020
SVP, COO & CFO
Sold, plan not stated
5,938
$132.71K
2.3%
NKTR NEKTAR THERAPEUTICS
18 Nov 2019
SVP, COO & CFO
Sold, plan not stated
8,863
$159.27K
3.9%
NKTR NEKTAR THERAPEUTICS
13 Nov 2019
SVP, COO & CFO
Sold, plan not stated
25,000
$494.75K
9.9%
NKTR NEKTAR THERAPEUTICS
15 Oct 2019
SVP, COO & CFO
Sold, plan not stated
25,000
$395.75K
9.9%
NKTR NEKTAR THERAPEUTICS
16 Sep 2019
SVP & Chief Financial Officer
Sold, plan not stated
25,000
$513.00K
14.1%
NKTR NEKTAR THERAPEUTICS
16 Aug 2019
SVP & Chief Financial Officer
Sold, plan not stated
5,063
$91.89K
4.0%
NKTR NEKTAR THERAPEUTICS
14 Aug 2019
SVP & Chief Financial Officer
Sold, plan not stated
25,000
$444.75K
16.3%
NKTR NEKTAR THERAPEUTICS
10 Jul 2019
SVP & Chief Financial Officer
Sold, plan not stated
25,000
$864.25K
16.3%
NKTR NEKTAR THERAPEUTICS
17 Jun 2019
SVP & Chief Financial Officer
Sold, plan not stated
25,000
$842.75K
16.3%
NKTR NEKTAR THERAPEUTICS
16 May 2019
SVP & Chief Financial Officer
Sold, plan not stated
3,767
$118.17K
2.9%
NKTR NEKTAR THERAPEUTICS
19 Feb 2019
SVP & Chief Financial Officer
Sold, plan not stated
3,592
$152.26K
2.7%
NKTR NEKTAR THERAPEUTICS
16 Nov 2018
SVP & Chief Financial Officer
Sold, plan not stated
6,515
$249.20K
5.8%
NKTR NEKTAR THERAPEUTICS
16 May 2018
SVP & Chief Financial Officer
Sold, plan not stated
4,941
$412.03K
5.0%
NKTR NEKTAR THERAPEUTICS
3 May 2018
SVP & Chief Financial Officer
Sold, plan not stated
30,000
$2.49M
23.1%
NKTR NEKTAR THERAPEUTICS
2 May 2018
SVP & Chief Financial Officer
Sold, plan not stated
30,000
$2.57M
23.1%
NKTR NEKTAR THERAPEUTICS
1 May 2018
SVP & Chief Financial Officer
Sold, plan not stated
30,000
$2.51M
23.1%
NKTR NEKTAR THERAPEUTICS
16 Feb 2018
SVP & Chief Financial Officer
Sold, plan not stated
3,477
$288.38K
3.4%
NKTR NEKTAR THERAPEUTICS
2 Oct 2017
SVP & Chief Financial Officer
Sold, plan not stated
120,000
$2.93M
65.4%
NKTR NEKTAR THERAPEUTICS
16 Aug 2017
SVP & Chief Financial Officer
Sold, plan not stated
3,177
$61.38K
4.8%
NKTR NEKTAR THERAPEUTICS
16 May 2017
SVP & Chief Financial Officer
Sold, plan not stated
3,179
$62.15K
4.6%
NKTR NEKTAR THERAPEUTICS
3 Mar 2017
SVP & Chief Financial Officer
Sold, plan not stated
32,494
$494.23K
31.9%
NKTR NEKTAR THERAPEUTICS
2 Mar 2017
SVP & Chief Financial Officer
Sold, plan not stated
167,506
$2.54M
70.7%
NKTR NEKTAR THERAPEUTICS
16 Feb 2017
SVP & Chief Financial Officer
Sold, plan not stated
2,359
$31.00K
3.3%
NKTR NEKTAR THERAPEUTICS
16 Nov 2016
SVP & Chief Financial Officer
Sold, plan not stated
1,654
$23.09K
3.1%
NKTR NEKTAR THERAPEUTICS
16 Aug 2016
SVP & Chief Financial Officer
Sold, plan not stated
3,305
$58.04K
5.9%
NKTR NEKTAR THERAPEUTICS
17 May 2016
SVP & General Counsel
Sold, plan not stated
836
$11.35K
9.5%
NKTR NEKTAR THERAPEUTICS
17 Feb 2016
SVP & General Counsel
Sold, plan not stated
827
$9.86K
11.2%
NKTR NEKTAR THERAPEUTICS
10 Feb 2016
SVP & General Counsel
Sold, plan not stated
11,666
$134.04K
69.0%
NKTR NEKTAR THERAPEUTICS
19 Jan 2016
SVP & General Counsel
Sold, plan not stated
11,667
$164.74K
69.0%
NKTR NEKTAR THERAPEUTICS
3 Dec 2015
SVP & General Counsel
Sold, plan not stated
45,001
$714.17K
89.6%
NKTR NEKTAR THERAPEUTICS
11 Nov 2015
SVP & General Counsel
Sold, plan not stated
45,000
$608.40K
90.5%
NKTR NEKTAR THERAPEUTICS
6 Oct 2015
SVP & General Counsel
Sold, plan not stated
45,000
$494.55K
90.5%
NKTR NEKTAR THERAPEUTICS
23 Sep 2015
SVP & General Counsel
Sold, plan not stated
44,999
$586.79K
90.5%
NKTR NEKTAR THERAPEUTICS
13 Aug 2015
SVP & General Counsel
Sold, plan not stated
33,333
$363.00K
87.5%
NKTR NEKTAR THERAPEUTICS
14 Jul 2015
SVP & General Counsel
Sold, plan not stated
33,334
$392.67K
88.7%
NKTR NEKTAR THERAPEUTICS
1 Dec 2014
SVP & General Counsel
Sold, plan not stated
30,000
$510.00K
87.6%
NKTR NEKTAR THERAPEUTICS
28 Nov 2014
SVP & General Counsel
Sold, plan not stated
90,000
$1.53M
95.5%
NKTR NEKTAR THERAPEUTICS
24 Nov 2014
SVP & General Counsel
Sold, plan not stated
10,500
$157.92K
73.7%
NKTR NEKTAR THERAPEUTICS
3 Nov 2014
SVP & General Counsel
Sold, plan not stated
9,900
$136.42K
72.5%
NKTR NEKTAR THERAPEUTICS
12 May 2009
SVP & General Counsel
Sold, plan not stated
395
$2.20K
12.9%
NKTR NEKTAR THERAPEUTICS
14 Nov 2008
SVP & General Counsel
Sold, plan not stated
401
$1.75K
16.9%
64 decisions on file.